Abstract:α-Synuclein (α-syn) fibrillar aggregates are the major component of Lewy bodies and Lewy neurites presenting as the pathology hallmark of Parkinson’s disease (PD). Studies have shown that α-syn is potential to form different conformational fibrils associated with different synucleinopathies, but whether the conformation of α-syn fibrils changes in different phases of related diseases is to be explored. Here, we amplified α-syn aggregates from the cerebrospinal fluid (CSF) of preclinical (pre-PD) and late-stage postmortem PD (post-PD) patients. Our results show that compared to the CSF of pre-PD, that of post-PD is markedly stronger in seeding in vitro α-syn aggregation, and the amplified fibrils are more potent in inducing endogenous α-syn aggregation in neurons. Cryo-electron microscopic structures further reveal that the difference between the pre-PD- and post-PD-derived fibrils lies on a minor polymorph which in the pre-PD fibrils is morphologically straight, while in the post-PD fibrils represents a single protofilament assembled by a distinctive conformation of α-syn. Our work demonstrates structural and pathological differences between pre-PD and post-PD α-syn aggregation and suggests potential alteration of α-syn fibrils during the progression of PD clinical phases. Significance Statement Increasing evidence support different conformational α-syn fibrils in patients with different α-synucleinopathies, but whether the conformation of α-syn fibrils changes in different phases of related diseases is unknown. Here, we show that α-syn fibrils amplified from the cerebrospinal fluid (CSF) of the late-stage postmortem PD (post-PD) patient are more potent in inducing endogenous α-syn aggregation in neurons than that amplified from the preclinical (pre-PD) patient. Cryo-EM structures further reveal that the post-PD fibrils contain a novel conformation that is distinct from either the pre-PD fibrils or those previously reported. Our work suggests conformational evolution of α-syn fibrils along with PD progression. ### Competing Interest Statement The authors have declared no competing interest.

Parkinson's disease-related phosphorylation at Tyr39 rearranges α-synuclein amyloid fibril structure revealed by cryo-EM.

Amyloid fibril structure of α-synuclein determined by cryo-electron microscopy

Parkinson’s disease associated mutation E46K of α-synuclein triggers the formation of a novel fibril structure

Phosphorylation and O-GlcNAcylation at the Same Α-Synuclein Site Generate Distinct Fibril Structures

Parkinson's disease associated mutation E46K of -synuclein triggers the formation of a distinct fibril structure

Structural Insights of Fe 3+ Induced α-synuclein Fibrillation in Parkinson's Disease

Alpha-synuclein phosphorylation induces amyloid conversion via enhanced electrostatic bridging: Insights from molecular modeling of the full-length protein

Exploring the role of post‐translational modifications in regulating α‐synuclein interactions by studying the effects of phosphorylation on nanobody binding

Phosphorylation Induces Distinct Alpha-Synuclein Strain Formation

Exploring the Roles of Post-Translational Modifications in the Pathogenesis of Parkinson's Disease Using Synthetic and Semisynthetic Modified Α-Synuclein.

Mechanistic basis for receptor-mediated pathological α-synuclein fibril cell-to-cell transmission in Parkinson's disease

Conformational change of α-synuclein fibrils in cerebrospinal fluid from different clinical phases of Parkinson's disease

Phosphorylation at Ser8 As an Intrinsic Regulatory Switch to Regulate the Morphologies and Structures of Alzheimer's 40-Residue Β-Amyloid (aβ40) Fibrils.

Different Charged Biopolymers Induce Α-Synuclein to Form Fibrils with Distinct Structures

Cryo-EM structure of alpha-synuclein fibrils amplified by PMCA from PD and MSA patient brains

Leucine Carboxyl Methyltransferase Downregulation and Protein Phosphatase Methylesterase Upregulation Contribute Toward the Inhibition of Protein Phosphatase 2A by α-Synuclein

Different structures and pathologies of α-synuclein fibrils derived from preclinical and postmortem patients of Parkinson’s disease

Impact of Phosphorylation on the Physiological Form of Human alpha-Synuclein in Aqueous Solution

Effect of Ser-129 Phosphorylation on Interaction of Α-Synuclein with Synaptic and Cellular Membranes.

Structural packing of the non-amyloid component core domain in α-synuclein plays a role in the stability of the fibrils

Aggregation and phase separation of α-synuclein in Parkinson's disease